News | Heart Failure | May 05, 2022

Study Reveals how Blood Vessels use “Short Cuts” to Control the Cardiovascular System

An invisible lining of blood vessels uses a vast network of connections to control all cardiovascular functions and the risk of developing cardiovascular disease. 

Blood cells travelling in vessel

Image: Getty Images


May 5, 2022 – Cardiovascular disease is a group of conditions that can arise from a lack of physical activity, poor diet, or certain disorders. Scientists have known that the development of these conditions begins with changes in vascular endothelial cells - the cells that line the body’s blood vessels. But why and how changes in endothelial cell function occur is not entirely clear.  

New research led at the University of Strathclyde’s Vascular Imaging Centre has shown that these cells use a sophisticated system to communicate with each other. Failures in this communication system may be the first step in the development of cardiovascular disease. 

The endothelium is the thin inner layer of cells in blood vessels and it regulates blood flow, blood pressure, blood clotting, inflammation and response to disease. It continually processes the vast amounts of information held in the composition of blood, and chemicals in the area around each blood vessel to keep the cardiovascular system working properly. 

The Strathclyde study has discovered that there are clusters of cells in the endothelium that are specialized to particular functions and they operate in cliques. Between cliques, numerous interlinked connections act to convey information and there is a high density of connections to protect the system against communication failures. The system bypasses neighboring cells by using short-cuts to transmit information quickly over distance.  

The findings reveal that the endothelial communication network design is similar to the communication operations of the internet and it is effective for local blood vessel control and global efficiency in determining overall cardiovascular activity. The design is robust, so that communication systems to control cardiovascular activity will not fail even when there is extensive damage.  

The findings also indicate that changes in the organization of communication, rather than behavior and function of individual cells, may underlie disease.  

The researchers addressed the nature of the communication network by using single-cell calcium ion imaging across thousands of endothelial cells in intact blood vessels and applying mathematical network (graph) theory. The study, conducted with the Karolinska Institutet in Stockholm, has been published in the journal Proceedings of the National Academy of Sciences (PNAS).  

Professor John McCarron, of Strathclyde Institute of Pharmacy and Biomedical Sciences, said: “Cells in the endothelium are a major target for the control of cardiovascular disease and are often treated as being a uniform population of cells. Our findings show the cells are not uniform but specialized to particular types of function.  

“There is a well-organized, rapid and robust communication system that shares information so that coordinated responses occur. The communication system offers new targets for therapy development and insights into why developing treatments has proven so difficult.”  

The research was funded by the British Heart Foundation and the Wellcome Trust.  


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now